Log in
One of the best ways to double, if not triple your investment in 2020 will be found in tech stocks. Especially those involved with the 5G rollout, where we're still finding undervalued opportunities. In our latest special report, we detail these and other hot tech stocks that should be part of your portfolio right now.

OTCMKTS:EMIS - Emisphere Technologies Stock Price, Forecast & News

-0.05 (-0.60 %)
(As of 01/24/2020 06:35 AM ET)
Today's Range
Now: $8.29
50-Day Range
MA: $6.57
52-Week Range
Now: $8.29
Volume39,746 shs
Average Volume61,409 shs
Market Capitalization$696.53 million
P/E RatioN/A
Dividend YieldN/A
Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:EMIS



Sales & Book Value

Annual SalesN/A



Market Cap$696.53 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMIS News and Ratings via Email

Sign-up to receive the latest news and ratings for EMIS and its competitors with MarketBeat's FREE daily newsletter.


If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Emisphere Technologies (OTCMKTS:EMIS) Frequently Asked Questions

What is Emisphere Technologies' stock symbol?

Emisphere Technologies trades on the OTCMKTS under the ticker symbol "EMIS."

How were Emisphere Technologies' earnings last quarter?

Emisphere Technologies, Inc. (OTCMKTS:EMIS) issued its quarterly earnings data on Friday, May, 12th. The company reported $0.04 EPS for the quarter. The company had revenue of $0.22 million for the quarter. View Emisphere Technologies' Earnings History.

Has Emisphere Technologies been receiving favorable news coverage?

Press coverage about EMIS stock has trended very positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Emisphere Technologies earned a news impact score of 3.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Emisphere Technologies.

Who are some of Emisphere Technologies' key competitors?

What other stocks do shareholders of Emisphere Technologies own?

Who are Emisphere Technologies' key executives?

Emisphere Technologies' management team includes the folowing people:
  • Mr. Alan L. Rubino, CEO, Pres & Director (Age 64)
  • Mr. Alan V. Gallantar CPA, Interim Chief Financial Officer (Age 61)

How do I buy shares of Emisphere Technologies?

Shares of EMIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Emisphere Technologies' stock price today?

One share of EMIS stock can currently be purchased for approximately $8.29.

How big of a company is Emisphere Technologies?

Emisphere Technologies has a market capitalization of $696.53 million. Emisphere Technologies employs 6 workers across the globe.View Additional Information About Emisphere Technologies.

What is Emisphere Technologies' official website?

The official website for Emisphere Technologies is http://www.emisphere.com/.

How can I contact Emisphere Technologies?

Emisphere Technologies' mailing address is 4 BECKER FARM ROAD SUITE 103, ROSELAND NJ, 07068. The company can be reached via phone at 973-532-8000 or via email at [email protected]

MarketBeat Community Rating for Emisphere Technologies (OTCMKTS EMIS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about Emisphere Technologies and other stocks. Vote "Outperform" if you believe EMIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel